Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Board Resignation of and Release Agreement with Mr. Davis

As previously announced, on September 30, 2026, ChronoScale Holdings Corporation, a Nevada corporation (the "Company") completed the sale of its wholly owned subsidiary, Ekso Bionics, Inc. ("Ekso"). In connection with the sale of Ekso (the "Transaction"), Scott Davis, a member of the Board of Directors of the Company (the "Board") and Chief Executive Officer ("CEO") of Ekso, resigned from his position as a member of the Board, effective as of October 3, 2026. There were no disagreements between the Company and Mr. Davis that led to his decision to resign. Also, in connection with the consummation of the Transaction, on October 2, 2026, the Company (i) granted an award of 51,626 restricted stock units ("RSUs") to Mr. Davis, which fully vested on the grant date, and (ii) entered into a Release Agreement with Mr. Davis (the "Release Agreement").

Pursuant to the Release Agreement, Mr. Davis is entitled to receive a lump sum cash payment of $709,500, less applicable withholdings and deductions (the "Release Payment"). The Release Payment is payable within 30 days of the execution of the Release Agreement. The Release Payment is subject to Mr. Davis's compliance with the Release Agreement and his continuing restrictive covenants. In exchange for the Release Payment, Mr. Davis has agreed to a general release of claims against the Company and its past, present, and future parent organizations, subsidiaries, and affiliated entities.

The Release Agreement also provides that it does not amend, alter, or modify the terms and conditions of the Phantom Performance-Based Restricted Stock Unit Agreement between ChronoScale Intermediate LLC, a wholly owned subsidiary of the Company ("ChronoScale Intermediate") and Mr. Davis dated November 5, 2025, as described in the Company's Current Report on Form 8-K filed with the SEC on November 7, 2025.

The Release Agreement was entered into in lieu of, and in full satisfaction of, any payment or benefit that Mr. Davis may otherwise have been entitled to receive pursuant to that certain Change in Control and Severance Agreement between ChronoScale Intermediate and Mr. Davis, dated November 5, 2025, filed with the SEC as Exhibit 10.2 to the Company's Current Report on Form 8-K on November 7, 2025.